Literature DB >> 6257486

Activation of adenosine 3',5'-monophosphate-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2, and prostacyclin.

N C Partridge, B E Kemp, M C Veroni, T J Martin.   

Abstract

Hormonal activation of cAMP-dependent protein kinase has been studied in cultured cells derived from a rat osteogenic sarcoma and in osteoblast-rich cells grown from newborn rat calvaria. Both cell strains contain adenylate cyclase activities which respond to parathyroid hormone (PTH) and a variety of prostanoids. PTH, prostaglandin E2 (PGE2), and prostacyclin (PGI2) were all capable of activating cAMP-dependent protein kinase(s) in suspensions of the two cell types. Activation was very rapid in all cases, being detectable at 10 sec and maximal between 30-60 sec. Using saturating concentrations of hormones, the protein kinase activity ratio remained elevated (between 0.6-0.9) for up to 35 min after the start of PGE2 stimulation, but declined toward basal activity ratio 5-10 min after stimulation with PTH or PGI2. Each of the hormones caused a dose-dependent increase in activation of cAMP-dependent protein kinase in both cell types. Half-maximal activation of the enzyme occurred at 2 X 10(-9) M bovine PTH for calvarial cells, at 10(-8) M bPTH for osteogenic sarcoma cells, and at 2-4 X 10(-8) M PGE2 and 1-3 X 10(-7) M PGI2 for both cell types. Maximal activation of protein kinase occurred before maximal cAMP accumulated, implying that only a fraction of cAMP is biologically significant. These two cell strains provide a useful means of analyzing postreceptor events in the hormonal regulation of bone cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257486     DOI: 10.1210/endo-108-1-220

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH.

Authors:  Jun Guo; Minlin Liu; Dehong Yang; Mary L Bouxsein; Clare C Thomas; Ernestina Schipani; F Richard Bringhurst; Henry M Kronenberg
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells.

Authors:  A C Kohl; D N Tatakis; C Hansen; R Dziak
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

Review 3.  The pathobiology of the osteoclast.

Authors:  T J Chambers
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

4.  Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.

Authors:  U H Lerner; M Ransjö; O Ljunggren
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

5.  Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.

Authors:  Zachary C Ryan; Theodore A Craig; Jeffrey L Salisbury; Lomeli R Carpio; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-04-26       Impact factor: 3.575

6.  Cyclic nucleotides and the rapid inhibitions of bone 45Ca uptake in response to bovine parathyroid hormone and 16,16-dimethyl prostaglandin E2 in chicks.

Authors:  A J Shaw; C G Dacke
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

7.  Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin.

Authors:  S M Forrest; K W Ng; D M Findlay; V P Michelangeli; S A Livesey; N C Partridge; J D Zajac; T J Martin
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

8.  Inhibitory effects of parathyroid hormone on growth of osteogenic sarcoma cells.

Authors:  N C Partridge; A L Opie; R T Opie; T J Martin
Journal:  Calcif Tissue Int       Date:  1985-09       Impact factor: 4.333

9.  Role of osteoblasts in hormonal control of bone resorption--a hypothesis.

Authors:  G A Rodan; T J Martin
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

10.  PTH1-34 blocks radiation-induced osteoblast apoptosis by enhancing DNA repair through canonical Wnt pathway.

Authors:  Abhishek Chandra; Tiao Lin; Ji Zhu; Wei Tong; Yanying Huo; Haoruo Jia; Yejia Zhang; X Sherry Liu; Keith Cengel; Bing Xia; Ling Qin
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.